First Page | Document Content | |
---|---|---|
Food and Drug Administration Pharmacology Therapeutics United States Public Health Service Medicinal chemistry Piperazines Pharmaceutical sciences Clinical research Clinical pharmacology | N20-408S033 Dorzolamide Amendment 2Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 120,37 KBShare Document on Facebook |